Skip to NavigationSkip to content

News

0
Researchers from the University of Bristol and NHS Blood and Transplant have managed to perfect a technique whereby it is possible to manufacture red...
0
Following on from the positive opinion given to Xeljanz in January of this year, Pfizer’s drug has now been given European Commission marketing...
0
Infectex, a Russian portfolio company of Maxwell Biotech Venture Fund, announced that it had found positive results from its latest Phase 2b-3...
0
AstraZeneca has been boosted by the news that its drug, Tagrisso, has become its first drug to be approved under China’s new Priority Review pathway.

Features

A rundown of five reasons to pay closer attention to the rise of fake medicines across the globe, including some hair-raising statistics on the...